Are you curious about this common disease but unsure how to handle its diagnosis, management, and biomarkers? Join a webinar the Lewy Body Dementia Association is hosting with Alzforum. On Tuesday, October 10 at 11 . EST , DLB research leaders Ian McKeith and John-Paul Taylor from Newcastle University, ., will discuss new consensus criteria issued by the DLB Consortium this past June. Growing out of the recent International Dementia with Lewy Body Conference , the criteria elevate the importance of REM sleep disorder and incorporate the biomarker MIBG. The hope is that the updated guidelines will help clinicians miss fewer DLB cases while also making this unique blend of a cognition/movement disorder tractable for clinical trials. Have you adopted the guidelines? Are they working? How are they informing your research? Register here , and bring your questions and comments.